Representative Paul Ray proposes the following substitute bill:


1     
CONTROLLED SUBSTANCE AMENDMENTS

2     
2017 GENERAL SESSION

3     
STATE OF UTAH

4     
Chief Sponsor: Paul Ray

5     
Senate Sponsor: Allen M. Christensen

6     Cosponsor:
Carol Spackman Moss

7     

8     LONG TITLE
9     General Description:
10          This bill modifies the Utah Controlled Substances Act.
11     Highlighted Provisions:
12          This bill:
13          ▸     adds the following to the list of controlled substances under Schedule I:
14               •     3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide, also
15     known as U-47700 or "pink";
16                •     Acetyl fentanyl: (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide);
17               •      Butyryl fentanyl: N-(1-(2-phenylethyl)-4-piperidinyl)-N-phenylbutyramide;
18               •      Furanyl fentanyl: and
19     N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide; and
20          ▸     adds the following to listed controlled substances:
21               •      ADB-CHMINACA: N-[(2S)-1-amino-3,3-dimethyl-1-oxobutan-2-yl]
22     -1-(cyclohexylmethyl)indazole-3-carboxamide;
23               •      ADB-FUBINACA: (N-(1-amino-3,3-dimethyl-1oxobutan-2-yl)
24     -1-(4-fluorobenzyl)-1H-indazole-3-caboxamide); and
25               •      FUB-AMB; methyl (1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)valinate.
26     Money Appropriated in this Bill:
27          None
28     Other Special Clauses:
29          This bill provides a special effective date.
30     Utah Code Sections Affected:
31     AMENDS:
32          58-37-4, as last amended by Laws of Utah 2015, Chapter 258
33          58-37-4.2, as last amended by Laws of Utah 2014, Chapter 23
34     

35     Be it enacted by the Legislature of the state of Utah:
36          Section 1. Section 58-37-4 is amended to read:
37          58-37-4. Schedules of controlled substances -- Schedules I through V -- Findings
38     required -- Specific substances included in schedules.
39          (1) There are established five schedules of controlled substances known as Schedules I,
40     II, III, IV, and V which consist of substances listed in this section.
41          (2) Schedules I, II, III, IV, and V consist of the following drugs or other substances by
42     the official name, common or usual name, chemical name, or brand name designated:
43          (a) Schedule I:
44          (i) Unless specifically excepted or unless listed in another schedule, any of the
45     following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and
46     ethers, when the existence of the isomers, esters, ethers, and salts is possible within the specific
47     chemical designation:
48          (A) Acetyl-alpha-methylfentanyl
49     (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);
50          (B) Acetyl fentanyl: (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide);
51          [(B)] (C) Acetylmethadol;
52          [(C)] (D) Allylprodine;
53          [(D)] (E) Alphacetylmethadol, except levo-alphacetylmethadol also known as
54     levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM;
55          [(E)] (F) Alphameprodine;
56          [(F)] (G) Alphamethadol;
57          [(G)] (H) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]
58     propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine);
59          [(H)] (I) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-
60     piperidinyl]-N-phenylpropanamide);
61          [(I)] (J) Benzylpiperazine;
62          [(J)] (K) Benzethidine;
63          [(K)] (L) Betacetylmethadol;
64          [(L)] (M) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-
65     piperidinyl]-N-phenylpropanamide);
66          [(M)] (N) Beta-hydroxy-3-methylfentanyl, other name: N-[1-(2-hydroxy-2-
67     phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide;
68          [(N)] (O) Betameprodine;
69          [(O)] (P) Betamethadol;
70          [(P)] (Q) Betaprodine;
71          (R) Butyryl fentanyl: N-(1-(2-phenylethyl)-4-piperidinyl)-N-phenylbutyramide;
72          [(Q)] (S) Clonitazene;
73          [(R)] (T) Dextromoramide;
74          [(S)] (U) Diampromide;
75          [(T)] (V) Diethylthiambutene;
76          [(U)] (W) Difenoxin;
77          [(V)] (X) Dimenoxadol;
78          [(W)] (Y) Dimepheptanol;
79          [(X)] (Z) Dimethylthiambutene;
80          [(Y)] (AA) Dioxaphetyl butyrate;
81          [(Z)] (BB) Dipipanone;
82          [(AA)] (CC) Ethylmethylthiambutene;
83          [(BB)] (DD) Etonitazene;
84          [(CC)] (EE) Etoxeridine;
85          (FF) Furanyl fentanyl: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]
86     furan-2-carboxamide
87          [(DD)] (GG) Furethidine;
88          [(EE)] (HH) Hydroxypethidine;
89          [(FF)] (II) Ketobemidone;
90          [(GG)] (JJ) Levomoramide;
91          [(HH)] (KK) Levophenacylmorphan;
92          [(II)] (LL) Morpheridine;
93          [(JJ)] (MM) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
94          [(KK)] (NN) Noracymethadol;
95          [(LL)] (OO) Norlevorphanol;
96          [(MM)] (PP) Normethadone;
97          [(NN)] (QQ) Norpipanone;
98          [(OO)] (RR) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-
99     piperidinyl] propanamide;
100          [(PP)] (SS) PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine);
101          [(QQ)] (TT) Phenadoxone;
102          [(RR)] (UU) Phenampromide;
103          [(SS)] (VV) Phenomorphan;
104          [(TT)] (WW) Phenoperidine;
105          [(UU)] (XX) Piritramide;
106          [(VV)] (YY) Proheptazine;
107          [(WW)] (ZZ) Properidine;
108          [(XX)] (AAA) Propiram;
109          [(YY)] (BBB) Racemoramide;
110          [(ZZ)] (CCC) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-
111     propanamide;
112          [(AAA)] (DDD) Tilidine;
113          [(BBB)] (EEE) Trimeperidine;
114          [(CCC)] (FFF) 3-methylfentanyl, including the optical and geometric isomers
115     (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]- N-phenylpropanamide); [and]
116          [(DDD)] (GGG) 3-methylthiofentanyl
117     (N-[(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide)[.]; and
118          [(EEE)] (HHH) 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide
119     also known as U-47700.
120          (ii) Unless specifically excepted or unless listed in another schedule, any of the
121     following opium derivatives, their salts, isomers, and salts of isomers when the existence of the
122     salts, isomers, and salts of isomers is possible within the specific chemical designation:
123          (A) Acetorphine;
124          (B) Acetyldihydrocodeine;
125          (C) Benzylmorphine;
126          (D) Codeine methylbromide;
127          (E) Codeine-N-Oxide;
128          (F) Cyprenorphine;
129          (G) Desomorphine;
130          (H) Dihydromorphine;
131          (I) Drotebanol;
132          (J) Etorphine (except hydrochloride salt);
133          (K) Heroin;
134          (L) Hydromorphinol;
135          (M) Methyldesorphine;
136          (N) Methylhydromorphine;
137          (O) Morphine methylbromide;
138          (P) Morphine methylsulfonate;
139          (Q) Morphine-N-Oxide;
140          (R) Myrophine;
141          (S) Nicocodeine;
142          (T) Nicomorphine;
143          (U) Normorphine;
144          (V) Pholcodine; and
145          (W) Thebacon.
146          (iii) Unless specifically excepted or unless listed in another schedule, any material,
147     compound, mixture, or preparation which contains any quantity of the following hallucinogenic
148     substances, or which contains any of their salts, isomers, and salts of isomers when the
149     existence of the salts, isomers, and salts of isomers is possible within the specific chemical
150     designation; as used in this Subsection (2)(a)(iii) only, "isomer" includes the optical, position,
151     and geometric isomers:
152          (A) Alpha-ethyltryptamine, some trade or other names: etryptamine; Monase;
153     α-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; α-ET; and AET;
154          (B) 4-bromo-2,5-dimethoxy-amphetamine, some trade or other names:
155     4-bromo-2,5-dimethoxy-α-methylphenethylamine; 4-bromo-2,5-DMA;
156          (C) 4-bromo-2,5-dimethoxyphenethylamine, some trade or other names:
157     2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB; 2C-B, Nexus;
158          (D) 2,5-dimethoxyamphetamine, some trade or other names:
159     2,5-dimethoxy-α-methylphenethylamine; 2,5-DMA;
160          (E) 2,5-dimethoxy-4-ethylamphetamine, some trade or other names: DOET;
161          (F) 4-methoxyamphetamine, some trade or other names:
162     4-methoxy-α-methylphenethylamine; paramethoxyamphetamine, PMA;
163          (G) 5-methoxy-3,4-methylenedioxyamphetamine;
164          (H) 4-methyl-2,5-dimethoxy-amphetamine, some trade and other names:
165     4-methyl-2,5-dimethoxy-α-methylphenethylamine; "DOM"; and "STP";
166          (I) 3,4-methylenedioxy amphetamine;
167          (J) 3,4-methylenedioxymethamphetamine (MDMA);
168          (K) 3,4-methylenedioxy-N-ethylamphetamine, also known as N-ethyl-
169     alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl MDA, MDE, MDEA;
170          (L) N-hydroxy-3,4-methylenedioxyamphetamine, also known as
171     N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine, and N-hydroxy MDA;
172          (M) 3,4,5-trimethoxy amphetamine;
173          (N) Bufotenine, some trade and other names:
174     3-(β-Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N,
175     N-dimethylserotonin; 5-hydroxy-N,N-dimethyltryptamine; mappine;
176          (O) Diethyltryptamine, some trade and other names: N,N-Diethyltryptamine; DET;
177          (P) Dimethyltryptamine, some trade or other names: DMT;
178          (Q) Ibogaine, some trade and other names:
179     7-Ethyl-6,6β,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido [1', 2':1,2] azepino
180     [5,4-b] indole; Tabernanthe iboga;
181          (R) Lysergic acid diethylamide;
182          (S) Marijuana;
183          (T) Mescaline;
184          (U) Parahexyl, some trade or other names:
185     3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran; Synhexyl;
186          (V) Peyote, meaning all parts of the plant presently classified botanically as
187     Lophophora williamsii Lemaire, whether growing or not, the seeds thereof, any extract from
188     any part of such plant, and every compound, manufacture, salts, derivative, mixture, or
189     preparation of such plant, its seeds or extracts (Interprets 21 USC 812(c), Schedule I(c) (12));
190          (W) N-ethyl-3-piperidyl benzilate;
191          (X) N-methyl-3-piperidyl benzilate;
192          (Y) Psilocybin;
193          (Z) Psilocyn;
194          (AA) Tetrahydrocannabinols, naturally contained in a plant of the genus Cannabis
195     (cannabis plant), as well as synthetic equivalents of the substances contained in the cannabis
196     plant, or in the resinous extractives of Cannabis, sp. and/or synthetic substances, derivatives,
197     and their isomers with similar chemical structure and pharmacological activity to those
198     substances contained in the plant, such as the following: Δ1 cis or trans tetrahydrocannabinol,
199     and their optical isomers Δ6 cis or trans tetrahydrocannabinol, and their optical isomers Δ3,4
200     cis or trans tetrahydrocannabinol, and its optical isomers, and since nomenclature of these
201     substances is not internationally standardized, compounds of these structures, regardless of
202     numerical designation of atomic positions covered;
203          (BB) Ethylamine analog of phencyclidine, some trade or other names:
204     N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl)ethylamine,
205     N-(1-phenylcyclohexyl)ethylamine, cyclohexamine, PCE;
206          (CC) Pyrrolidine analog of phencyclidine, some trade or other names:
207     1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP;
208          (DD) Thiophene analog of phencyclidine, some trade or other names:
209     1-[1-(2-thienyl)-cyclohexyl]-piperidine, 2-thienylanalog of phencyclidine, TPCP, TCP; and
210          (EE) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine, some other names: TCPy.
211          (iv) Unless specifically excepted or unless listed in another schedule, any material
212     compound, mixture, or preparation which contains any quantity of the following substances
213     having a depressant effect on the central nervous system, including its salts, isomers, and salts
214     of isomers when the existence of the salts, isomers, and salts of isomers is possible within the
215     specific chemical designation:
216          (A) Mecloqualone; and
217          (B) Methaqualone.
218          (v) Any material, compound, mixture, or preparation containing any quantity of the
219     following substances having a stimulant effect on the central nervous system, including their
220     salts, isomers, and salts of isomers:
221          (A) Aminorex, some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; or
222     4,5-dihydro-5-phenyl-2-oxazolamine;
223          (B) Cathinone, some trade or other names: 2-amino-1-phenyl-1-propanone,
224     alpha-aminopropiophenone, 2-aminopropiophenone, and norephedrone;
225          (C) Fenethylline;
226          (D) Methcathinone, some other names: 2-(methylamino)-propiophenone;
227     alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one;
228     alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone;
229     methylcathinone; AL-464; AL-422; AL-463 and UR1432, its salts, optical isomers, and salts of
230     optical isomers;
231          (E) (±)cis-4-methylaminorex ((±)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine);
232          (F) N-ethylamphetamine; and
233          (G) N,N-dimethylamphetamine, also known as
234     N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine.
235          (vi) Any material, compound, mixture, or preparation which contains any quantity of
236     the following substances, including their optical isomers, salts, and salts of isomers, subject to
237     temporary emergency scheduling:
238          (A) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl); and
239          (B) N-[1- (2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl).
240          (vii) Unless specifically excepted or unless listed in another schedule, any material,
241     compound, mixture, or preparation which contains any quantity of gamma hydroxy butyrate
242     (gamma hydrobutyric acid), including its salts, isomers, and salts of isomers.
243          (b) Schedule II:
244          (i) Unless specifically excepted or unless listed in another schedule, any of the
245     following substances whether produced directly or indirectly by extraction from substances of
246     vegetable origin, or independently by means of chemical synthesis, or by a combination of
247     extraction and chemical synthesis:
248          (A) Opium and opiate, and any salt, compound, derivative, or preparation of opium or
249     opiate, excluding apomorphine, dextrorphan, nalbuphine, nalmefene, naloxone, and naltrexone,
250     and their respective salts, but including:
251          (I) Raw opium;
252          (II) Opium extracts;
253          (III) Opium fluid;
254          (IV) Powdered opium;
255          (V) Granulated opium;
256          (VI) Tincture of opium;
257          (VII) Codeine;
258          (VIII) Ethylmorphine;
259          (IX) Etorphine hydrochloride;
260          (X) Hydrocodone;
261          (XI) Hydromorphone;
262          (XII) Metopon;
263          (XIII) Morphine;
264          (XIV) Oxycodone;
265          (XV) Oxymorphone; and
266          (XVI) Thebaine;
267          (B) Any salt, compound, derivative, or preparation which is chemically equivalent or
268     identical with any of the substances referred to in Subsection (2)(b)(i)(A), except that these
269     substances may not include the isoquinoline alkaloids of opium;
270          (C) Opium poppy and poppy straw;
271          (D) Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and
272     any salt, compound, derivative, or preparation which is chemically equivalent or identical with
273     any of these substances, and includes cocaine and ecgonine, their salts, isomers, derivatives,
274     and salts of isomers and derivatives, whether derived from the coca plant or synthetically
275     produced, except the substances may not include decocainized coca leaves or extraction of coca
276     leaves, which extractions do not contain cocaine or ecgonine; and
277          (E) Concentrate of poppy straw, which means the crude extract of poppy straw in either
278     liquid, solid, or powder form which contains the phenanthrene alkaloids of the opium poppy.
279          (ii) Unless specifically excepted or unless listed in another schedule, any of the
280     following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and
281     ethers, when the existence of the isomers, esters, ethers, and salts is possible within the specific
282     chemical designation, except dextrorphan and levopropoxyphene:
283          (A) Alfentanil;
284          (B) Alphaprodine;
285          (C) Anileridine;
286          (D) Bezitramide;
287          (E) Bulk dextropropoxyphene (nondosage forms);
288          (F) Carfentanil;
289          (G) Dihydrocodeine;
290          (H) Diphenoxylate;
291          (I) Fentanyl;
292          (J) Isomethadone;
293          (K) Levo-alphacetylmethadol, some other names: levo-alpha-acetylmethadol,
294     levomethadyl acetate, or LAAM;
295          (L) Levomethorphan;
296          (M) Levorphanol;
297          (N) Metazocine;
298          (O) Methadone;
299          (P) Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane;
300          (Q) Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic
301     acid;
302          (R) Pethidine (meperidine);
303          (S) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine;
304          (T) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate;
305          (U) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid;
306          (V) Phenazocine;
307          (W) Piminodine;
308          (X) Racemethorphan;
309          (Y) Racemorphan;
310          (Z) Remifentanil; and
311          (AA) Sufentanil.
312          (iii) Unless specifically excepted or unless listed in another schedule, any material,
313     compound, mixture, or preparation which contains any quantity of the following substances
314     having a stimulant effect on the central nervous system:
315          (A) Amphetamine, its salts, optical isomers, and salts of its optical isomers;
316          (B) Methamphetamine, its salts, isomers, and salts of its isomers;
317          (C) Phenmetrazine and its salts; and
318          (D) Methylphenidate.
319          (iv) Unless specifically excepted or unless listed in another schedule, any material,
320     compound, mixture, or preparation which contains any quantity of the following substances
321     having a depressant effect on the central nervous system, including its salts, isomers, and salts
322     of isomers when the existence of the salts, isomers, and salts of isomers is possible within the
323     specific chemical designation:
324          (A) Amobarbital;
325          (B) Glutethimide;
326          (C) Pentobarbital;
327          (D) Phencyclidine;
328          (E) Phencyclidine immediate precursors: 1-phenylcyclohexylamine and
329     1-piperidinocyclohexanecarbonitrile (PCC); and
330          (F) Secobarbital.
331          (v) (A) Unless specifically excepted or unless listed in another schedule, any material,
332     compound, mixture, or preparation which contains any quantity of Phenylacetone.
333          (B) Some of these substances may be known by trade or other names:
334     phenyl-2-propanone; P2P; benzyl methyl ketone; and methyl benzyl ketone.
335          (vi) Nabilone, another name for nabilone:
336     (±)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,
337     6-dimethyl-9H-dibenzo[b,d]pyran-9-one.
338          (c) Schedule III:
339          (i) Unless specifically excepted or unless listed in another schedule, any material,
340     compound, mixture, or preparation which contains any quantity of the following substances
341     having a stimulant effect on the central nervous system, including its salts, isomers whether
342     optical, position, or geometric, and salts of the isomers when the existence of the salts, isomers,
343     and salts of isomers is possible within the specific chemical designation:
344          (A) Those compounds, mixtures, or preparations in dosage unit form containing any
345     stimulant substances listed in Schedule II, which compounds, mixtures, or preparations were
346     listed on August 25, 1971, as excepted compounds under Section 1308.32 of Title 21 of the
347     Code of Federal Regulations, and any other drug of the quantitive composition shown in that
348     list for those drugs or which is the same except that it contains a lesser quantity of controlled
349     substances;
350          (B) Benzphetamine;
351          (C) Chlorphentermine;
352          (D) Clortermine; and
353          (E) Phendimetrazine.
354          (ii) Unless specifically excepted or unless listed in another schedule, any material,
355     compound, mixture, or preparation which contains any quantity of the following substances
356     having a depressant effect on the central nervous system:
357          (A) Any compound, mixture, or preparation containing amobarbital, secobarbital,
358     pentobarbital, or any salt of any of them, and one or more other active medicinal ingredients
359     which are not listed in any schedule;
360          (B) Any suppository dosage form containing amobarbital, secobarbital, or
361     pentobarbital, or any salt of any of these drugs which is approved by the Food and Drug
362     Administration for marketing only as a suppository;
363          (C) Any substance which contains any quantity of a derivative of barbituric acid or any
364     salt of any of them;
365          (D) Chlorhexadol;
366          (E) Buprenorphine;
367          (F) Any drug product containing gamma hydroxybutyric acid, including its salts,
368     isomers, and salts of isomers, for which an application is approved under the federal Food,
369     Drug, and Cosmetic Act, Section 505;
370          (G) Ketamine, its salts, isomers, and salts of isomers, some other names for ketamine:
371     ± -2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone;
372          (H) Lysergic acid;
373          (I) Lysergic acid amide;
374          (J) Methyprylon;
375          (K) Sulfondiethylmethane;
376          (L) Sulfonethylmethane;
377          (M) Sulfonmethane; and
378          (N) Tiletamine and zolazepam or any of their salts, some trade or other names for a
379     tiletamine-zolazepam combination product: Telazol, some trade or other names for tiletamine:
380     2-(ethylamino)-2-(2-thienyl)-cyclohexanone, some trade or other names for zolazepam:
381     4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e] [1,4]-diazepin-7(1H)-one,
382     flupyrazapon.
383          (iii) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a
384     U.S. Food and Drug Administration approved drug product, some other names for dronabinol:
385     (6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol, or
386     (-)-delta-9-(trans)-tetrahydrocannabinol.
387          (iv) Nalorphine.
388          (v) Unless specifically excepted or unless listed in another schedule, any material,
389     compound, mixture, or preparation containing limited quantities of any of the following
390     narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid:
391          (A) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90
392     milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of
393     opium;
394          (B) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90
395     milligrams per dosage unit, with one or more active non-narcotic ingredients in recognized
396     therapeutic amounts;
397          (C) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more
398     than 15 milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline
399     alkaloid of opium;
400          (D) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more
401     than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in
402     recognized therapeutic amounts;
403          (E) Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90
404     milligrams per dosage unit, with one or more active non-narcotic ingredients in recognized
405     therapeutic amounts;
406          (F) Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more
407     than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in
408     recognized therapeutic amounts;
409          (G) Not more than 500 milligrams of opium per 100 milliliters or per 100 grams, or not
410     more than 25 milligrams per dosage unit, with one or more active, non-narcotic ingredients in
411     recognized therapeutic amounts; and
412          (H) Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams with
413     one or more active, non-narcotic ingredients in recognized therapeutic amounts.
414          (vi) Unless specifically excepted or unless listed in another schedule, anabolic steroids
415     including any of the following or any isomer, ester, salt, or derivative of the following that
416     promotes muscle growth:
417          (A) Boldenone;
418          (B) Chlorotestosterone (4-chlortestosterone);
419          (C) Clostebol;
420          (D) Dehydrochlormethyltestosterone;
421          (E) Dihydrotestosterone (4-dihydrotestosterone);
422          (F) Drostanolone;
423          (G) Ethylestrenol;
424          (H) Fluoxymesterone;
425          (I) Formebulone (formebolone);
426          (J) Mesterolone;
427          (K) Methandienone;
428          (L) Methandranone;
429          (M) Methandriol;
430          (N) Methandrostenolone;
431          (O) Methenolone;
432          (P) Methyltestosterone;
433          (Q) Mibolerone;
434          (R) Nandrolone;
435          (S) Norethandrolone;
436          (T) Oxandrolone;
437          (U) Oxymesterone;
438          (V) Oxymetholone;
439          (W) Stanolone;
440          (X) Stanozolol;
441          (Y) Testolactone;
442          (Z) Testosterone; and
443          (AA) Trenbolone.
444          (vii) Anabolic steroids expressly intended for administration through implants to cattle
445     or other nonhuman species, and approved by the Secretary of Health and Human Services for
446     use, may not be classified as a controlled substance.
447          (d) Schedule IV:
448          (i) Unless specifically excepted or unless listed in another schedule, any material,
449     compound, mixture, or preparation containing not more than 1 milligram of difenoxin and not
450     less than 25 micrograms of atropine sulfate per dosage unit, or any salts of any of them.
451          (ii) Unless specifically excepted or unless listed in another schedule, any material,
452     compound, mixture, or preparation which contains any quantity of the following substances,
453     including its salts, isomers, and salts of isomers when the existence of the salts, isomers, and
454     salts of isomers is possible within the specific chemical designation:
455          (A) Alprazolam;
456          (B) Barbital;
457          (C) Bromazepam;
458          (D) Butorphanol;
459          (E) Camazepam;
460          (F) Carisoprodol;
461          (G) Chloral betaine;
462          (H) Chloral hydrate;
463          (I) Chlordiazepoxide;
464          (J) Clobazam;
465          (K) Clonazepam;
466          (L) Clorazepate;
467          (M) Clotiazepam;
468          (N) Cloxazolam;
469          (O) Delorazepam;
470          (P) Diazepam;
471          (Q) Dichloralphenazone;
472          (R) Estazolam;
473          (S) Ethchlorvynol;
474          (T) Ethinamate;
475          (U) Ethyl loflazepate;
476          (V) Fludiazepam;
477          (W) Flunitrazepam;
478          (X) Flurazepam;
479          (Y) Halazepam;
480          (Z) Haloxazolam;
481          (AA) Ketazolam;
482          (BB) Loprazolam;
483          (CC) Lorazepam;
484          (DD) Lormetazepam;
485          (EE) Mebutamate;
486          (FF) Medazepam;
487          (GG) Meprobamate;
488          (HH) Methohexital;
489          (II) Methylphenobarbital (mephobarbital);
490          (JJ) Midazolam;
491          (KK) Nimetazepam;
492          (LL) Nitrazepam;
493          (MM) Nordiazepam;
494          (NN) Oxazepam;
495          (OO) Oxazolam;
496          (PP) Paraldehyde;
497          (QQ) Pentazocine;
498          (RR) Petrichloral;
499          (SS) Phenobarbital;
500          (TT) Pinazepam;
501          (UU) Prazepam;
502          (VV) Quazepam;
503          (WW) Temazepam;
504          (XX) Tetrazepam;
505          (YY) Triazolam;
506          (ZZ) Zaleplon; and
507          (AAA) Zolpidem.
508          (iii) Any material, compound, mixture, or preparation of fenfluramine which contains
509     any quantity of the following substances, including its salts, isomers whether optical, position,
510     or geometric, and salts of the isomers when the existence of the salts, isomers, and salts of
511     isomers is possible.
512          (iv) Unless specifically excepted or unless listed in another schedule, any material,
513     compound, mixture, or preparation which contains any quantity of the following substances
514     having a stimulant effect on the central nervous system, including its salts, isomers whether
515     optical, position, or geometric isomers, and salts of the isomers when the existence of the salts,
516     isomers, and salts of isomers is possible within the specific chemical designation:
517          (A) Cathine ((+)-norpseudoephedrine);
518          (B) Diethylpropion;
519          (C) Fencamfamine;
520          (D) Fenproprex;
521          (E) Mazindol;
522          (F) Mefenorex;
523          (G) Modafinil;
524          (H) Pemoline, including organometallic complexes and chelates thereof;
525          (I) Phentermine;
526          (J) Pipradrol;
527          (K) Sibutramine; and
528          (L) SPA ((-)-1-dimethylamino-1,2-diphenylethane).
529          (v) Unless specifically excepted or unless listed in another schedule, any material,
530     compound, mixture, or preparation which contains any quantity of dextropropoxyphene
531     (alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane), including its salts.
532          (e) Schedule V: Any compound, mixture, or preparation containing any of the
533     following limited quantities of narcotic drugs, or their salts calculated as the free anhydrous
534     base or alkaloid, which includes one or more non-narcotic active medicinal ingredients in
535     sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal
536     qualities other than those possessed by the narcotic drug alone:
537          (i) not more than 200 milligrams of codeine per 100 milliliters or per 100 grams;
538          (ii) not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100
539     grams;
540          (iii) not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100
541     grams;
542          (iv) not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of
543     atropine sulfate per dosage unit;
544          (v) not more than 100 milligrams of opium per 100 milliliters or per 100 grams;
545          (vi) not more than 0.5 milligram of difenoxin and not less than 25 micrograms of
546     atropine sulfate per dosage unit;
547          (vii) unless specifically exempted or excluded or unless listed in another schedule, any
548     material, compound, mixture, or preparation which contains Pyrovalerone having a stimulant
549     effect on the central nervous system, including its salts, isomers, and salts of isomers; and
550          (viii) all forms of Tramadol.
551          Section 2. Section 58-37-4.2 is amended to read:
552          58-37-4.2. Listed controlled substances.
553          The following substances, their analogs, homologs, and synthetic equivalents are listed
554     controlled substances:
555          (1) AB-001;
556          (2) AB-PINACA;
557     N-[1-(aminocarbonyl)-2-methylpropyl]-1-pentyl-1H-indazole-3-carboxamide;
558          (3) AB-FUBINACA; N-[1-(aminocarbonyl)-2-methylpropyl]-1-[(4-fluorophenyl)
559     methyl]-1H-indazole-3-carboxamide;
560          (4) ADB-CHMINACA: N-[(2S)-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1-
561     (cyclohexylmethyl)indazole-3-carboxamide;
562          (5) ADB-FUBINACA: (N-(1-amino-3,3-dimethyl-1oxobutan-2-yl)-1-
563     (4-fluorobenzyl)-1H-indazole-3-caboxamide);
564          [(4)] (6) AKB48;
565          [(5)] (7) alpha-Pyrrolidinovalerophenone (alpha-PVP);
566          [(6)] (8) AM-694; 1-[(5-fluoropentyl)-1H-indol-3-yl]-(2-iodophenyl)methanone;
567          [(7)] (9) AM-1248;
568          [(8)] (10) AM-2201; 1-(5-fluoropentyl)-3-(1-naphthoyl)indole;
569          [(9)] (11) AM-2233;
570          [(10)] (12) AM-679;
571          [(11)] (13) A796,260;
572          [(12)] (14) Butylone;
573          [(13)] (15) CP 47,497 and its C6, C8, and C9 homologs;
574     2-[(1R,3S)-3-hydroxycyclohexyl] -5-(2-methyloctan-2-yl)phenol;
575          [(14)] (16) Diisopropyltryptamine (DiPT);
576          [(15)] (17) Ethylone;
577          [(16)] (18) Ethylphenidate;
578          [(17)] (19) Fluoroisocathinone;
579          [(18)] (20) Fluoromethamphetamine;
580          [(19)] (21) Fluoromethcathinone;
581          (22) FUB-AMB; methyl (1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)valinate;
582          [(20)] (23) HU-210;
583     (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)
584     -6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;
585          [(21)] (24) HU-211; Dexanabinol,(6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-
586     methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;
587          [(22)] (25) JWH-015; (2-methyl-1-propyl-1H-indol-3-yl)-1-naphthalenyl-methanone;
588          [(23)] (26) JWH-018; Naphthalen-1-yl-(pentylindol-3-yl)methanone {also known as
589     1-Pentyl-3-(1-naphthoyl)indole};
590          [(24)] (27) JWH-019; 1-hexyl-3-(1-naphthoyl)indole;
591          [(25)] (28) JWH-073; Naphthalen-1-yl(1-butylindol-3-yl)methanone {also known as
592     1-Butyl-3-(1-naphthoyl)indole};
593          [(26)] (29) JWH-081; 4-methoxynaphthalen-1-yl-(1-pentylindol-3-yl)methanone;
594          [(27)] (30) JWH-122; CAS#619294-47-2; (1-Pentyl-3-(4-methyl-1-naphthoyl)indole);
595          [(28)] (31) JWH-200; 1-(2-(4-(morpholinyl)ethyl))-3-(1-naphthoyl)indole;
596          [(29)] (32) JWH-203; 1-pentyl-3-(2-chlorophenylacetyl)indole;
597          [(30)] (33) JWH-210; 4-ethyl-1-naphthalenyl(1-pentyl-1H-indol-3-yl)-methanone;
598          [(31)] (34) JWH-250; 1-pentyl-3-(2-methoxyphenylacetyl)indole;
599          [(32)] (35) JWH-251; 2-(2-methylphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone;
600          [(33)] (36) JWH-398; 1-pentyl-3-(4-chloro-1-naphthoyl)indole;
601          [(34)] (37) MAM-2201;
602          [(35)] (38) MAM-2201;
603     (1-(5-fluoropentyl)-1H-indol-3-yl)(4-ethyl-1-naphthalenyl)-methanone;
604          [(36)] (39) Methoxetamine;
605          [(37)] (40) Naphyrone;
606          [(38)] (41) PB-22; 1-pentyl-1H-indole-3-carboxylic acid 8-quinolinyl ester;
607          [(39)] (42) Pentedrone;
608          [(40)] (43) Pentylone;
609          [(41)] (44) RCS-4; 1-pentyl-3-(4-methoxybenzoyl)indole;
610          [(42)] (45) RCS-8; 1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole {also
611     known as BTW-8 and SR-18};
612          [(43)] (46) STS-135;
613          [(44)] (47) UR-144;
614          [(45)] (48) UR-144 N-(5-chloropentyl) analog;
615          [(46)] (49) XLR11;
616          [(47)] (50) 2C-C;
617          [(48)] (51) 2C-D;
618          [(49)] (52) 2C-E;
619          [(50)] (53) 2C-H;
620          [(51)] (54) 2C-I;
621          [(52)] (55) 2C-N;
622          [(53)] (56) 2C-P;
623          [(54)] (57) 2C-T-2;
624          [(55)] (58) 2C-T-4;
625          [(56)] (59) 2NE1;
626          [(57)] (60) 25I-NBOMe;
627          [(58)] (61) 2,5-Dimethoxy-4-chloroamphetamine (DOC);
628          [(59)] (62) 4-methylmethcathinone {also known as mephedrone};
629          [(60)] (63) 3,4-methylenedioxypyrovalerone {also known as MDPV};
630          [(61)] (64) 3,4-Methylenedioxymethcathinone {also known as methylone};
631          [(62)] (65) 4-methoxymethcathinone;
632          [(63)] (66) 4-Methyl-alpha-pyrrolidinopropiophenone;
633          [(64)] (67) 4-Methylethcathinone;
634          [(65)] (68) 5F-AKB48;
635     1-(5-flouropentyl)-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3- carboxamide;
636          [(66)] (69) 5-fluoro-PB-22; 1-(5-fluoropentyl)-1H-indole-3-carboxylic acid
637     8-quinolinyl ester;
638          [(67)] (70) 5-Iodo-2-aminoindane (5-IAI);
639          [(68)] (71) 5-MeO-DALT;
640          [(69)] (72) 25B-NBOMe; 2-(r-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)
641     methyl]ethanamine;
642          [(70)] (73) 25C-NBOMe; 2-(4Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)
643     methyl]ethanamine; and
644          [(71)] (74) 25H-NBOMe;
645     2-(2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine.
646          Section 3. Effective date.
647          If approved by two-thirds of all the members elected to each house, this bill takes effect
648     upon approval by the governor, or the day following the constitutional time limit of Utah
649     Constitution, Article VII, Section 8, without the governor's signature, or in the case of a veto,
650     the date of veto override.